Mitofusin Inhibitor Composition for Stem Cell Reprogramming Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reprogramming differentiated cells into pluripotent stem cells face inefficiencies and challenges in maintaining pluripotency, particularly due to the limitations of p53 and mitochondrial dynamics, which affect cell cycle progression and metabolic reprogramming.
Innovation Solution
The use of a composition comprising a repressor of mitofusin gene expression or an inhibitor of mitofusin protein activity to promote dedifferentiation and maintain pluripotency, including the use of antisense oligonucleotides, siRNA, shRNA, or specific compounds like tetramethylpyrazine and U74389G maleate to downregulate mitofusin activity, facilitating a shift from mitochondrial to glycolytic metabolism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional reprogramming methods are used to reprogram differentiated cells into pluripotent stem cells, then reprogramming can occur, but the reprogramming efficiency is low and the process is time-consuming
Solution Approach 1:
The invention extracts and removes the limiting factor (mitofusin protein) that prevents efficient reprogramming. By using specific inhibitors to block mitofusin activity, the patent removes the mitochondrial fusion barrier that normally constrains reprogramming efficiency, allowing cells to transition to pluripotency much more rapidly and efficiently.
Solution Approach 2:
The invention changes the metabolic state parameter of the cells by inhibiting mitofusin, which shifts cells from oxidative phosphorylation to glycolysis. This parameter change in metabolic mode creates a permissive state for rapid reprogramming, transforming the cellular environment to favor pluripotency acquisition.
2Reliability
If p53 pathway is active to maintain genome stability, then cell cycle arrest and senescence occur to protect against reprogramming-induced stress, but this limits cell fate transition and reduces reprogramming efficiency
Solution Approach 1:
The invention converts the harmful effect of active p53 (which blocks reprogramming) into a benefit by using mitofusin inhibition to indirectly suppress p53 activity. The mitofusin inhibitor creates a metabolic shift that leads to reduced p53-mediated cell cycle arrest, allowing efficient reprogramming while maintaining genome stability through alternative mechanisms.
3Stability of the object's composition
If mitofusin activity is maintained to support mitochondrial ATP production, then cellular homeostasis is maintained, but reprogramming efficiency is reduced and pluripotency maintenance is impaired
Solution Approach 1:
The invention introduces dynamic control of mitochondrial function by temporarily inhibiting mitofusin during the reprogramming process. This dynamic approach allows the system to switch from a stable mitochondrial state to a plastic metabolic state conducive to reprogramming, and then potentially restore homeostasis in the pluripotent state.
Solution Approach 2:
The invention changes the metabolic parameter from oxidative phosphorylation to glycolysis by inhibiting mitofusin. This parameter change creates the metabolic flexibility needed for reprogramming while maintaining cellular homeostasis through alternative energy pathways.
Data Source
Figure 1a~1b
Figure 1c~1d
Figure 1e
AI summary
The present invention relates to a composition comprising a repressor of mitofusin gene expression, an inhibitor of mitofusin protein activity, or a mixture thereof as an active ingredient for promoting reprogramming a differentiated cell into a pluripotent stem cell, and a use thereof. The composition according to the present invention increases the efficiency of reprogramming as well as reduces the time required for reprogramming to produce pluripotent stem cells. Therefore, the present composition can be beneficially used to develop the production technology of high efficiency pluripotent stem cell and secure a large-scale culture system. Further, the present composition can be beneficially used to maintain pluripotent stem cells and screen the compounds capable of promoting the reprogramming into pluripotent stem cells.